IPO Trending
ZENITHDRUGSME / NSEListed

Zenith Drugs Limited

Zenith Drugs Limited, founded in 2000, is a pharmaceutical company that manufactures and trades affordable, high-quality medicines, including various generic products. The company operates under WHO-GMP guidelines and holds an ISO 9001:2015 certification, reflecting its focus on quality. It offers a wide product range such as ORS powder, liquid orals, ointments, liquid externals, and capsules, with over 600 products approved by the Food & Drugs Administration and 325 currently in production. Zenith Drugs is expanding by setting up a new manufacturing facility in Muradpura, Depalpur, Indore, and it also exports its products to multiple regions including Central America, Africa, Southeast Asia, and South Asia. The company provides third-party manufacturing services to well-known pharmaceutical brands like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, and as of March 31, 2023, it employs 89 people, including both payroll and contract staff.

₹75 - ₹79179.07x sub
Listed Price110.00
Listing Gain+39.24%
Subscription179.07x total demandUpdated 20 Nov 2025, 07:04 AM
QIB106.72x
🔥 Blockbuster Sizzling Demand!Offered: 8,59,200 sh
Nib369.94x
🔥 Blockbuster Sizzling Demand!Offered: 6,44,800 sh
Retail138.57x
🔥 Blockbuster Sizzling Demand!Offered: 15,04,000 sh
CategoryOfferedAppliedTimes
QIB8,59,2009,16,97,600106.72x
Nib6,44,80023,85,39,200369.94x
Retail15,04,00020,84,04,800138.57x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB724.416.79106.69x
Retail1,646.411.88138.59x